Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Schild

Showing results (201-210 of 220) with videos related to

Pageof 22
Sort By:
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|August 27, 2013
Automated quantification of pulmonary perfused blood volume by dual-energy CTPA in chronic thromboembolic pulmonary hypertensionF G Meinel, A Graef, K M Thierfelder, et al.
The Journal of Hygiene|June 1, 1983
A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunityA Clark, C W Potter, R Jennings, et al.
The Journal of Hygiene|June 1, 1983
A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunityA Clark, C W Potter, R Jennings, et al.
Journal of Virology|March 1, 1986
Construction of poliovirus intertypic recombinants by use of cDNAG Stanway, P J Hughes, G D Westrop, et al.
Nucleic Acids Research|March 11, 1983
Poliovirus type 3: molecular cloning of the genome and nucleotide sequence of the region encoding the protease and polymerase proteinsA J Cann, G Stanway, R Hauptmann, et al.
The Journal of General Virology|May 1, 1986
Antigenic and molecular properties of type 3 poliovirus responsible for an outbreak of poliomyelitis in a vaccinated populationD I Magrath, D M Evans, M Ferguson, et al.
Biochemical Society Symposium|January 1, 1987
Studies on the genetic basis of attenuation of the Sabin type 3 poliovirus vaccineJ W Almond, G D Westrop, K A Wareham, et al.
Vaccine|September 1, 1984
New poliovirus vaccines: a molecular approachJ W Almond, G Stanway, A J Cann, et al.
Bulletin of the World Health Organization|January 1, 1987
Infectivity and reactogenicity of reassortant cold-adapted influenza A/Korea/1/82 vaccines obtained from the USA and USSRK G Nicholson, D A Tyrrell, J S Oxford, et al.
European Journal of Biochemistry|October 3, 1983
Nucleic acid sequence of the region of the genome encoding capsid protein VP1 of neurovirulent and attenuated type 3 poliovirusesG Stanway, A J Cann, R Hauptmann, et al.
Pageof 22

Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|August 27, 2013
Automated quantification of pulmonary perfused blood volume by dual-energy CTPA in chronic thromboembolic pulmonary hypertensionF G Meinel, A Graef, K M Thierfelder, et al.
The Journal of Hygiene|June 1, 1983
A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunityA Clark, C W Potter, R Jennings, et al.
The Journal of Hygiene|June 1, 1983
A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunityA Clark, C W Potter, R Jennings, et al.
Journal of Virology|March 1, 1986
Construction of poliovirus intertypic recombinants by use of cDNAG Stanway, P J Hughes, G D Westrop, et al.
Nucleic Acids Research|March 11, 1983
Poliovirus type 3: molecular cloning of the genome and nucleotide sequence of the region encoding the protease and polymerase proteinsA J Cann, G Stanway, R Hauptmann, et al.
The Journal of General Virology|May 1, 1986
Antigenic and molecular properties of type 3 poliovirus responsible for an outbreak of poliomyelitis in a vaccinated populationD I Magrath, D M Evans, M Ferguson, et al.
Biochemical Society Symposium|January 1, 1987
Studies on the genetic basis of attenuation of the Sabin type 3 poliovirus vaccineJ W Almond, G D Westrop, K A Wareham, et al.
Vaccine|September 1, 1984
New poliovirus vaccines: a molecular approachJ W Almond, G Stanway, A J Cann, et al.
Bulletin of the World Health Organization|January 1, 1987
Infectivity and reactogenicity of reassortant cold-adapted influenza A/Korea/1/82 vaccines obtained from the USA and USSRK G Nicholson, D A Tyrrell, J S Oxford, et al.
European Journal of Biochemistry|October 3, 1983
Nucleic acid sequence of the region of the genome encoding capsid protein VP1 of neurovirulent and attenuated type 3 poliovirusesG Stanway, A J Cann, R Hauptmann, et al.
Pageof 22